U

Unicycive Therapeutics
D

UNCY

7.10000
USD
-1.10
(-13.41%)
Post Trading·7.12000USD+0.02000(+0.28%)
حجم التداول
139,129
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
194,490,492
المقالات
المزيد

العنوان: Unicycive Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two keyproduct candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.